Project Details
Description
Eicosapentaenoic acid activation of free fatty acid receptor 4 prevents fibrosis, microvascular rarefaction, and diastolic dysfunction; implications for heart failure preserved ejection fraction
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/17 → 12/31/19 |
Funding
- AMARIN PHARMA, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.